TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $3.495B (100.0% shares, 0.0% debt)

Holdings (49)

New Positions (11)

Increased Positions (8)

Decreased Positions (10)

Unchanged Positions (20)

CGON CG ONCOLOGY INC 7.1%
Value $248M Shares 3,670,206 Est. Cost $40.67 Unrealized +28.9%
DNTH DIANTHUS THERAPEUTICS INC 4.0%
Value $141M Shares 1,676,624 Est. Cost $25.70 Unrealized +85.2%
CNTA CENTESSA PHARMACEUTICALS PLC 4.9%
Value $170M Shares 4,286,480 Est. Cost $12.97 Unrealized
SYRE SPYRE THERAPEUTICS INC 2.7%
Value $95.87M Shares 1,900,582 Est. Cost $20.44 Unrealized +68.9%
FULC FULCRUM THERAPEUTICS INC 1.2%
Value $40.27M Shares 5,250,000 Est. Cost $7.42 Unrealized +39.8%
KOD KODIAK SCIENCES INC 1.6%
Value $55.1M Shares 1,445,538 Est. Cost $7.55 Unrealized +236.8%
BHVN BIOHAVEN LTD 1.1%
Value $39.18M Shares 4,631,317 Est. Cost $12.39 Unrealized -5.1%
AMLX AMYLYX PHARMACEUTICALS INC 2.5%
Value $86.79M Shares 6,243,812 Est. Cost $2.86 Unrealized +388.3%
XNCR XENCOR INC 0.8%
Value $29.57M Shares 2,452,138 Est. Cost $18.82 Unrealized -32.7%
SVRA SAVARA INC 1.9%
Value $67.5M Shares 12,362,205 Est. Cost $3.73 Unrealized +52.5%
DYN DYNE THERAPEUTICS INC 2.4%
Value $83.67M Shares 4,615,144 Est. Cost $14.30 Unrealized +19.7%
ALEC ALECTOR INC 0.6%
Value $21.5M Shares 10,000,000 Est. Cost $1.77 Unrealized +7.5%
GLUE MONTE ROSA THERAPEUTICS INC 2.2%
Value $76.03M Shares 4,622,151 Est. Cost $13.48 Unrealized +53.3%
ADCT ADC THERAPEUTICS SA 1.2%
Value $42.71M Shares 11,390,175 Est. Cost $3.95 Unrealized -2.9%
SLN SILENCE THERAPEUTICS PLC 0.5%
Value $15.99M Shares 3,033,560 Est. Cost $14.21 Unrealized
KRRO KORRO BIO INC 0.1%
Value $4.713M Shares 416,301 Est. Cost $22.19 Unrealized -51.4%
LONA LEONABIO INC 0.1%
Value $4.667M Shares 464,398 Est. Cost $4.58 Unrealized +22.8%
MBX MBX BIOSCIENCES INC 0.6%
Value $19.4M Shares 650,000 Est. Cost $22.87 Unrealized +61.1%
VTGN VISTAGEN THERAPEUTICS INC 0.0%
Value $1.53M Shares 2,676,580 Est. Cost $3.41 Unrealized -82.2%
JANX JANUX THERAPEUTICS INC 0.7%
Value $24.88M Shares 1,789,617 Est. Cost $23.52 Unrealized -41.9%